✦ LIBER ✦

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

✍ Scribed by Hochhaus, A; O'Brien, S G; Guilhot, F; Druker, B J; Branford, S; Foroni, L; Goldman, J M; Müller, M C; Radich, J P; Rudoltz, M; Mone, M; Gathmann, I; Hughes, T P; Larson, R A

Book ID: 118675788
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 608 KB
Volume: 23
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2009.38

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Six-year follow-up of patients receiving

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

✍ Hochhaus, A; O'Brien, S G; Guilhot, F; Druker, B J; Branford, S; Foroni, L; Gold 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 55 KB

Expenditure and effectiveness of treatme

Expenditure and effectiveness of treatment options in chronic myeloid leukemia patients who failed in the first-line imatinib treatment

✍ Chen, W.; Zhu, J.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

First-line treatment of 102 chronic myel

First-line treatment of 102 chronic myeloid leukemia patients with imatinib: A long-term single institution analysis

✍ Viganò, Ilaria; Di Giacomo, Nunzio; Bozzani, Sofia; Antolini, Laura; Piazza, Roc 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

PCN63 The Relative Value of Dasatinib Ve

PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia

✍ L. Betegon; I. Gilloteau; P. Martin; A. Woolmore; I. Oyagüez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Molecular responses of late chronic phas

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

✍ YaZhen Qin; Bin Jiang; Qian Jiang; Hao Jiang; JinLan Li; Yan Zhang; HongHu Zhu; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 117 KB

First line treatment of chronic phase ch

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

✍ Eskazan, Ahmet Emre; Ayer, Mesut; Kantarcioglu, Bulent; Arica, Deniz; Demirel, N 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB